Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
<i>Col2a1-CreER<sup>T2</sup>;Kdm6b<sup>f/f</sup></i> mice exhibited accelerated OA development at 8 and 12 weeks following surgical induction.
|
28314754 |
2017 |
Degenerative polyarthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
In grades II and III OA cartilage, the expression of miR-146a and COL2A1 was decreased, whereas the expression of matrix metalloproteinase 13 (MMP-13) was elevated in grade II OA cartilage.
|
19333945 |
2009 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lack of association between osteoarthritis of the hip and gene polymorphisms of VDR, COL1A1, and COL2A1 in postmenopausal women.
|
9811048 |
1998 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We demonstrated no evidence of linkage between the COL2A1/VDR locus and nonsyndromic DDH (LOD score < -2), suggesting, although variants in these genes could play a role in osteoarthritis in patients with DDH, they do not contribute to nonsyndromic DDH.
|
18288556 |
2008 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To investigate the relationships between two COL2A1 single nucleotide polymorphisms (SNPs; T2088C and G4006A) and osteoarthritis (OA) in Han Chinese women.
|
21088911 |
2011 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study.
|
22763110 |
2012 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
<b>Results:</b> The results of ELISA (IL-1β and tumor necrosis factor-α), the histological evaluation (Mankin and OARSI score), western blotting [COL2A1, matrix metalloproteinase (MMP)-3, MMP-13, IL-1β, and nuclear factor-kappaB (NF-κB) p65], and immunohistochemistry (COL2A1, MMP-3, and MMP-13) indicated that oral CAR attenuated the development of T2DM-induced OA and suppressed the inflammatory response.
|
29928231 |
2018 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We analyzed the COL2A1 gene in a 27-year-old woman and her 47-year-old mother presenting with severe premature osteoarthrosis and X-ray signs compatible with mild spondyloepiphyseal dysplasia.
|
7866404 |
1994 |
Degenerative polyarthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Compared with the normal group, the expression of ALK1, SMAD1, COL10A1 and MMP3 was higher in the OA groups, whereas the expression of COL2A1 was lower in the OA groups.
|
29753378 |
2018 |
Degenerative polyarthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, SAHA rescued the COL2A1 and ACAN expression in OA chondrocytes that was down-regulated by IL-1β.
|
27555113 |
2016 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hereditary osteoarthritis with mild spondyloepiphyseal dysplasia--are there "hot spots" on COL2A1?
|
8877930 |
1996 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Despite studies suggesting associations of OA with both COL2A1 and VDR loci, our results suggest that mutations at the COL2A1/VDR locus do not play an important role as a cause of common OA in the population at large.
|
11824954 |
2002 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
The differences reached significance (p ≤ 0.05) for seven of these ten quantified genes, with CXCL3, CXCL6, and COL2A1 being elevated in the femoroacetabular impingement group compared with only the control group and IL-8, CCL3L1, ADAMTS-4, and ACAN being elevated compared with both the osteoarthritis and control groups.
|
23965695 |
2013 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Further, Wogonin exhibits potent chondroprotective potential by switching the signaling axis of matrix degradation from catabolic towards anabolic ends and inhibited the expression, production and activities of matrix degrading proteases including MMP-13, MMP-3, MMP-9, and ADAMTS-4 in OA chondrocytes, and blocked the release of s-GAG and COL2A1 in IL-1β-stimulated OA cartilage explants.
|
28237856 |
2017 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Osteoarthritis in children associated with a mutation in the type II procollagen gene (COL2A1).
|
11708863 |
2001 |
Degenerative polyarthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
There was a significant decrease in aggrecan and type II collagen (COL2A1) gene expressions by 73% (p = 0.029) and 65% (p = 0.029), respectively, in advanced OA area compared with the minimally OA area.
|
21728837 |
2011 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Inhibition of ADAMTSs markedly increased the production of COL2A1, ACAN and COMP in chondrocytes isolated from the early stage of OA.
|
26162802 |
2015 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
The COL2A1 was not a susceptibility gene responsible for the OA phenotype in a large extended kindred with familial early-onset OA.
|
19223283 |
2009 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The cartilage collagen genes, COL2A1, COL9A1, COL9A2, COL9A3, COL11A1 and COL11A2, were screened for sequence variations in 72 Finnish probands and one US family with primary early-onset hip and/or knee OA.
|
15922184 |
2005 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Furthermore, expression of several key mRNAs associated with OA, including those for matrix metalloproteinase (MMP)-9, MMP-13, bone morphogenetic protein (BMP)-2, COL2A1 and ADAMTS5, was investigated by RT-PCR in OA and normal cartilage.
|
25430712 |
2014 |
Degenerative polyarthritis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
A significant correlation was, however, observed for H19, COL2A1, and miR-675 expression levels in OA tissue, and functional regulation of these candidate molecules was assessed under anabolic and catabolic conditions.
|
22527881 |
2012 |
Degenerative polyarthritis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Adjacent genes, for COL2A1 and the vitamin D receptor, are associated with separate features of radiographic osteoarthritis of the knee.
|
10902746 |
2000 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
We have previously demonstrated that Smurf2 is highly expressed in human osteoarthritis (OA) tissue, and overexpression of Smurf2 under the control of the type II collagen promoter (Col2a1) induces an OA-like phenotype in aged Col2a1-Smurf2 transgenic mice, suggesting that Smurf2 is located upstream of a signal cascade which initiates OA development.
|
19481076 |
2009 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
CTD_human |
Abnormal craniofacial growth and early mandibular osteoarthritis in mice harbouring a mutant type II collagen transgene.
|
9061443 |
1997 |
Degenerative polyarthritis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Our studies have identified two susceptibility loci of OA: COL2A1 and COL9A3.
|
12096843 |
2002 |